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Objective: Neuroinflammation in utero may result in life-long neurological disabilities.
The molecular mechanisms whereby microglia contribute to this response remain
incompletely understood.
Methods: Lipopolysaccharide (LPS) or saline were administered intravenously
to non-anesthetized chronically instrumented near-term fetal sheep to model fetal
inflammation in vivo. Microglia were then isolated from in vivo LPS and saline (naïve)
exposed animals. To mimic the second hit of neuroinflammation, these microglia were
then re-exposed to LPS in vitro. Cytokine responses were measured in vivo and
subsequently in vitro in the primary microglia cultures derived from these animals. We
sequenced the whole transcriptome of naïve and second hit microglia and profiled their
genetic expression to define molecular pathways disrupted during neuroinflammation.
Results: In vivo LPS exposure resulted in IL-6 increase in fetal plasma 3 h post LPS
exposure. Even though not histologically apparent, microglia acquired a pro-inflammatory
phenotype in vivo that was sustained and amplified in vitro upon second hit LPS
exposure as measured by IL-1β response in vitro and RNAseq analyses. While NFKB and
Jak-Stat inflammatory pathways were up regulated in naïve microglia, heme oxygenase
1 (HMOX1) and Fructose-1,6-bisphosphatase (FBP) genes were uniquely differentially
expressed in the second hit microglia. Compared to the microglia exposed to LPS in vitro
only, the transcriptome of the in vivo LPS pre-exposed microglia showed a diminished
differential gene expression in inflammatory and metabolic pathways prior and upon
re-exposure to LPS in vitro. Notably, this desensitization response was also observed in
histone deacetylases (HDAC) 1, 2, 4, and 6. Microglial calreticulin/LRP genes implicated
in microglia-neuronal communication relevant for the neuronal development were up
regulated in second hit microglia.
Discussion: We identified a unique HMOX1down and FBP
up phenotype of microglia
exposed to the double-hit suggesting interplay of inflammatory and metabolic pathways.
Cao et al. Fetal microglia in vivo and in vitro
Our findings suggest that epigenetic mechanisms mediate this immunological and
metabolic memory of the prior inflammatory insult relevant to neuronal development and
provide new therapeutic targets for early postnatal intervention to prevent brain injury.
Keywords: brain, neuroinflammation, bioinformatics, RNAseq, sheep, metabolism, cytokines, epigenetics
Introduction
Brain injury acquired antenatally remains a major cause of long-
term neurodevelopmental sequelae (Saigal and Doyle, 2008).
There is growing clinical and experimental evidence for maternal
and fetal infection acting via systemic and neuroinflammation to
cause fetal brain injury or contributing to in utero asphyxial brain
injury with consequences for postnatal health (Hagberg et al.,
2002; Rees and Inder, 2005; Wang et al., 2006; Gotsch et al., 2007;
Murthy and Kennea, 2007; Fahey, 2008).
In humans, the main cause of fetal inflammation is
chorioamnionitis, a frequent condition affecting 10% of all
pregnancies and up to 40% of preterm births. Chorioamnionitis
is associated with ∼nine-fold increased risk for cerebral palsy
spectrum disorders with life lasting neurological deficits and an
increased risk for acute or life-long morbidity and mortality
(Fahey, 2008; Agrawal and Hirsch, 2012; Fishman and Gelber,
2012).
In addition to short-term brain damage, neuroimmune
responses to in utero infection may also have long-term health
consequences, the “second hit” hypothesis: In adults, exposure
to inflammatory stimuli can activate microglia (glial priming,
reviewed in Billiards et al., 2006; Karrow, 2006; Bilbo and
Schwarz, 2009; Bilbo and Tsang, 2010; Ajmone-Cat et al., 2013;
Bolton et al., 2014).
We hypothesized that an inflammatory response induced by
lipopolysaccharide (LPS) will result in microglial activation
reflecting neuroinflammation. To test the “second hit”
hypothesis, we developed a protocol to culture fetal sheep
microglia and re-expose them to LPS under in vitro
conditions allowing a more mechanistic study of their
phenotype.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with
the recommendations in the Guide for the Care and
Use of Laboratory Animals of the National Institutes
of Health. The respective in vivo and in vitro protocols
were approved by the Committee on the Ethics of Animal
Experiments of the Université de Montréal (Permit Number:
10-Rech-1560).
Anesthesia and Surgical Procedure
We instrumented pregnant time-dated ewes at 126 days
of gestation (dGA, ∼0.86 gestation) with arterial, venous
and amniotic catheters and ECG electrodes (Frasch et al.,
2007). Ovine singleton fetuses of mixed breed were surgically
instrumented with sterile technique under general anesthesia
(both ewe and fetus). In case of twin pregnancy the larger fetus
was chosen based on palpating and estimating the intertemporal
diameter. The total duration of the procedure was approximately
2 h. Antibiotics were administered to the mother intravenously
(trimethoprim sulfadoxine 5mg/kg body weight) as well as to
the fetus intravenously and into the amniotic cavity (ampicillin
250 mg). Amniotic fluid lost during surgery was replaced with
warm saline. The catheters exteriorized through the maternal
flank were secured to the back of the ewe in a plastic pouch.
For the duration of the experiment the ewe was returned
to a metabolic cage, where she could stand, lie and eat ad
libitum while we monitored the non-anesthetized fetus without
sedating the mother. During postoperative recovery antibiotic
administration was continued for 3 days. Arterial blood was
sampled for evaluation of maternal and fetal condition and
catheters were flushed with heparinized saline to maintain
patency.
In vivo Experimental Protocol
Postoperatively, all animals were allowed 3 days to recover before
starting the experiments. On these 3 days, at 9.00 am 3mL
arterial plasma sample were taken for blood gasses and cytokine
analysis. Each experiment commenced at 9.00 am with a 1 h
baseline measurement followed by the respective intervention as
outlined below. FHR and arterial blood pressure was monitored
continuously (CED, Cambridge, UK, and NeuroLog, Digitimer,
Hertfordshire, UK). Blood samples (3mL) were taken for arterial
blood gasess, lactate, glucose, and base excess (ABL800Flex,
Radiometer) and cytokines at the time points 0 (baseline), +1
(i.e., after LPS administration), +3, +6, +24, +48, and +54 h
(i.e., before sacrifice at day 3). For the cytokine analysis, plasma
was spun at 4◦C (4min, 4000 g, Eppendorf 5804R, Mississauga,
ON), decanted and stored at−80◦C for subsequent ELISAs. After
the +54 h (Day 3) sampling, the animals were sacrificed with an
overdose of barbiturate (30mg pentobarbital sodium, Fatal-Plus;
Vortech Pharmaceuticals, Dearborn, MI) and a post mortem
was carried out during which fetal gender and weight were
determined. The fetal brain was then perfusion-fixedwith 250mL
of cold saline followed by 250mL of 4% paraformaldehyde
and processed for histochemical analysis or dissected for
cell culture (details see in vitro microglia culture paragraph).
Fetal growth was assessed by body, brain, liver, and maternal
weights.
Nine fetuses were used as controls receiving NaCl 0.9%.
Twelve fetuses received LPS (400 ng/fetus/day) derived from E.
coli (Sigma L5293, from E. coli O111:B4, ready-made solution
containing 1mg/ml of LPS) were administered intravenously to
fetuses on days 1 and 2 at 10.00 am to mimic high levels of
endotoxin in fetal circulation over several days as it may occur
in chorioamnionitis.
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In vitro Microglia Culture Protocol
Fetal sheep brain tissues were obtained during sheep autopsy
after completion of the experiment for in vitro study (Figure 1A).
The non-instrumented, untreated twins were designated “naïve”
(NC, no LPS exposure in vivo) and NL when exposed to LPS
in vitro for the first time. Instrumented animals that received LPS
in vivo (SHC) were used for 2nd hit LPS exposure in vitro (SHL).
Fetal sheep microglia culture protocol was adapted from an
established human adult and fetal microglia culture protocol that
was modified to include a myelin removal step following high-
speed centrifugation (Durafourt et al., 2013). Briefly, fetal sheep
cells were plated on poly-L-lysine (PLL)-coated tissue culture
flasks at a concentration of 2 × 106 cells /ml in DMEM with
5% heat-inactivated fetal bovine serum (Gibco, Canada Origin),
1% penicillin/ streptomycin, and 1% glutamine (5% DMEM), in
which microglia are preferable to grow (Durafourt et al., 2013).
Cells were allowed to incubate for seven days at 37◦C, 5% CO2,
followed by media change by centrifugation and addition of re-
suspended cells back to the culture flask. Cells were continued
to incubate for seven more days with 5% DMEM at 37◦C, 5%
CO2, before floating cells were collected. Carefully collecting the
floating microglia to avoid contamination with astrocytes and
oligodendrocytes, the cells were incubated in 24-well plates at
1 × 105 cells/1.82 cm2 surface area with 1mL of 5% DMEM for
another 4–5 days, and then treated with or w/o LPS (100 ng/ml,
Sigma L5024, from E. coli O127, B8) for 6 h. Cell conditioned
media were collected for cytokine analysis, 0.5ml TriZol were
added per well for RNA extraction.
To verify microglia purity, a portion of floating cells were
cultured in 24-well plates at above conditions for flow cytometry
analysis, cell morphology was documented with light microscopy
(see Supplementary Material). Another portion of floating cells
were plated into Lab-Tek eight well chamber glass slide (Thermo
Scientific) and treated with or w/o LPS for immunocytochemistry
FIGURE 1 | Fetal sheep in vivo LPS exposure causes a systemic
inflammation. (A) Experimental design. In vivo, in vitro and RNAseq
experiments are illustrated. In vivo study, Control (saline) and LPS;
in vitro study, cultured cells derived from in vivo Control animal, named
as Naïve, whereas cells derived from LPS-exposed animal named as
2nd hit (second hit, SH), there are four experimental groups: naïve
Control (NC), naïve LPS (NL ), 2nd hit control (SHC), and 2nd hit LPS
(SHL ), respectively. For RNAseq data comparisons, we first compared
pair 1 (n = 6) Control (NC) vs. LPS-exposed naïve microglia (NL ); then
pair 2 (n = 4) naïve control (NC) vs. 2nd hit Control (SHC); and finally
pair 3 (n = 4) naïve LPS-exposed microglia (NL ) vs. 2nd hit
LPS-exposed microglia (SHL ). (B) IL-6 levels peaked at 3 h in fetal
sheep plasma following LPS administration in vivo (***P < 0.001). In vivo
Control group, n = 9, in vivo LPS group, n = 12. Blood samples were
collected in heparinized syringe from fetal arterial catheter, plasma was
obtained by centrifugation. A sheep specific IL-6 ELISA was performed
to measure the cytokine levels. (C) No evidence of Iba1+ fetal brain
microglia inflammatory response to LPS exposure in vivo. Normalized
Iba1 + signal (microglia) fluorescence in six randomly chosen high power
fields per brain region is shown in hippocampus [CA1, CA234, and
dentate gyrus (DG) subregions], cortical gray matter (GM) layers GM13,
GM46, white matter (WM), and thalamus. GEE model for prediction of
Iba1+ normalized signal intensity: group main effect p = 0.62; brain
region main effect p < 0.001; brain region*group interaction p = 0.13.
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analysis, in this experiment, some wells of astrocytes cultured at
DMEM with 10% FCS were included for comparison.
Measurements of Inflammatory Responses
Measurement of Cytokines in Plasma and Cell
Culture Media
Cytokine concentrations in plasma (IL-6) and cell culture media
(IL-1β) were determined by using an ovine-specific sandwich
ELISA. Briefly, 96-well plates (Nunc Maxisorp, high capacity
microtitre wells) were pre-coated with the capture antibody,
the mouse anti sheep monoclonal antibodies (IL-6, MCA1659;
IL-1β, MCA1658, Bio Rad AbD Serotec) at a concentration
4µg/ml on ELISA plates at 4◦C for overnight, after 3 times
wash with washing buffer (0.05% Tween 20 in PBS, PBST),
plates were then blocked for 1 h with 1% BSA in PBST for
plasma samples or 10% FBS for cell culture media. Recombinant
sheep proteins (IL-6, Protein Express Cat. no 968-305; IL-1 β,
Cat. no 968-405) were used as ELISA standard. All standards
and samples (50µl per well) were run in duplicate. Rabbit anti
sheep polyclonal antibodies (detection antibody IL-6, AHP424;
IL-1β, AHP423, Bio Rad AbD Serotec) at a concentration of
4µg/ml were applied in wells and incubated for 30min at
room temperature. Plates were washed with washing buffer
for 5–7 times between each step. Detection was accomplished
by assessing the conjugated enzyme activity (goat anti-rabbit
IgG-HRP, dilution 1:5000, Jackson ImmunoResearch, Cat. No
111-035-144) via incubation with TMB substrate solution (BD
OptEIA TMB substrate Reagent Set, BD Biosciences Cat. No
555214), color development reaction was stopped with 2 N
sulphuric acid. Plates were read on ELISA plate reader at 450 nm,
with 570 nm wavelength correction (EnVision 2104 Multilabel
Reader, Perkin Elmer). The sensitivity of IL-6 ELISA for plasma
was 16 pg/ml, the sensitivity of IL-1b ELISA for media was
41.3 pg/ml, respectively. For all assays, the intra-assay and inter-
assay coefficients of variance was<5 and<10%, respectively.
Immunofluorescence Imaging Analysis
Complete brain was taken from the fetus during necropsy after
perfusion and immediately immersed in 4% PFA for 48–72 h.
The tissue sample was then washed and stored in 1× PBS buffer
changed daily for 3 days. Finally, the brain was stored in 70%
ethanol until further processing. All the brain tissue samples
were kept at 4◦C when they were in liquid. The fetal brains were
cut into two equal halves of left and right hemispheres, and then
sliced coronally and placed into cassettes to be processed with
Leica TP 1020 Automatic Tissue Processor (Leica Instruments,
Mussloch, Germany). The tissues were embedded in paraffinwith
Leica EG 1160 Paraffin Embedding Center (Leica Instruments,
Mussloch, Germany). Five-micrometer slices were obtained
from slicing the embedded tissue samples with the Leica RM2145
RotaryMicrotome (Leica Instruments, Mussloch, Germany), and
mounted on the Fisherbrand Colorfrost Plus microscope slides
(Fischer Scientific). The sectioned brain tissue samples went
through de-paraffinization with CitroSolv (Fischer Scientific),
100, 95, 70, and 50% ethanol at room temperature, and antigen
retrieval with 10mM citrate buffer at pH 6 before being washed
with water and 1× PBS, and blocked by Background Sniper
Blocking Reagent (Biocare Medical, Cat. No BS966JJ). Then the
sections were incubated with the primary antibody (Iba1, rabbit
polyclonal antibody 4, 1:250 dilution, Wako, Cat No. 019-19741)
for 1 h, followed by washing with 1× PBS and incubation
with secondary antibody (Alexa Fluor 568 goat anti-rabbit
IgG, 1:400 dilution, Life Technologies, Cat no A-11011) for
30min in the dark. After that, the sections were washed again
with 1× PBS, and the nuclei were counterstained with DAPI
(1:4000 dilution, Sigma D-9564). Finally, the sections were
cover-slipped with Fisherfinest Premium Cover glass (22× 50-1,
Fisher Scientific) and Fluoromount-G (SouthernBiotech, Cat no
0100-01) mounting medium, and viewed after 24 h of drying.
Widefield fluorescence microscopy was performed on the
stained brain tissue samples with a Zeiss Axiovert 200M inverted
microscope (Jena, Germany), at the magnification of 40× using
a HBO100 mercury-arc lamp as a light source. The images
were captured using a Zeiss Axiocam HRm (high-resolution
monochrome) CCD (charged-coupled device) camera. Six high
power field (HPF) images at 40× magnification were obtained
for each animal. Multichannel imaging was used with the Iba1
channel and the DAPI channel for obtaining the pictures used
for macrophage quantification. Appropriate ranges of color were
selected showing positive contiguous cytoplasmic staining as
a criterion for microglia cell count scoring which were then
applied uniformly to calibrated images for all brain regions
(Figure 2). Scoring was performed in a blinded fashion to
experimental groups. To normalize for cell density Iba1+ signal
over the whole area measured (100 sq micron) was divided by
the respective optical intensity values for each HPF according to
Lin et al. (2000).
RNAseq Approach
To extract and quantify RNA, total RNA was extracted from
cultured microglia using TRIzol Reagent (Life Technologies).
To obtain enough RNA, same treatment cells were pooled
in one replicate. RNA quantity and quality (RNA integrity
number, RIN) was determined by using a RNA Nano Chips
(Agilent RNA 6000 Nano Chips) with Agilent 2100 BioAnalyzer.
All samples had a RIN-value ranging from 6 to 8.5, except
for one sample having RIN = 5.5 but an acceptable 84% of
transcripts mapped, which did not affect the read count for this
sample.
A total of eight samples from four set of replicates were
selected for RNA sequencing at high throughput, of which three
replicates were derived from in vivo control fetal sheep and one
replicate was from in vivo LPS-exposed (second hit) fetal sheep.
RNAseq libraries were prepared by using Illumina TruSeq RNA
Sample Preparation v2 kit (Illumina) and quality control was
performed on the BioAnalyzer. Single-end 50-bp sequencing was
performed at high throughput on an Illumina HiSeq2500 at the
CHU Ste-Justine Core Facility Sequencing Platform. Raw data
and RNAseq data discussed in this publication were deposited on
NCBI and are accessible online with the GEO accession number
GSE71037.
RNAseq Data Analysis
Reads alignment to the reference genome
To maximize the amount of genes covered, raw data were
mapped to the reference genome of the sheep Ovis aris v3.1
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FIGURE 2 | Purity validation of fetal sheep brain primary microglia in
cultures and LPS second hit. (A) Photomicrographs (ICC) confirming cell
purity. Iba1+ staining in microglia vs. undetectable GFAP signal in microglia
indicating no contamination with astrocytes in the culture. Microglia were
cultured in eight-well chamber slide with DMEM +5% FCS for 4–7 days.
Microglia were collected from the floating fraction and stained for Iba1 and
GFAP. Scale bar = 50µm. Magnification 40× for both images. (B) Purity of
fetal sheep brain primary microglia cultures was verified by flowcytometry.
After several days in culture, fetal sheep microglia were scraped from the
wells using a cell scraper and blocked for 30min using normal mouse IgG
and 10% human serum. Cells were then stained using a FITC-conjugated
monoclonal bovine anti-CD11b (1:40, Bio-Rad) on ice for 20min. Cells were
washed in FACS buffer and analyzed using a BD FACSCalibur and FlowJo
software. (C) Microglia from in vivo LPS exposed brain appear more
aggregated in vitro than microglia derived from in vivo controls. Microglia
were cultured in 24-well plates with DMEM +5% FCS for 4–7 days, when
images were taken. Cells were extracted from a twin control fetal brain and
an in vivo LPS exposed fetal brain (Magnification 20× for both images). (D)
Effect of “second-hit” in vitro LPS treatment on microglial phenotype.
BOTTOM: IL-1β concentration in conditioned media of microglia derived from
fetal sheep brain that were exposed to LPS vs. saline in vivo (***P < 0.0001).
Cultures from in vivo LPS-exposed (SH), n = 4, cultures from in vivo Control
(Naïve), n = 10. Cell culture media supernatant was obtained by
centrifugation upon cell culture termination. A sheep specific IL-1β ELISA
was performed to measure cytokine levels in cell culture media. In vitro, at
baseline, microglia secreted more IL-1β in the in vivo LPS group (SHC) than
in naïve Control (NC). LPS re-exposure (SHL ) further increased IL-1β vs. naïve
LPS (NL ) by ∼4.6-fold.
from NCBI and Ensembl (GCA_000298735.1) as transcriptome
reference. Index of the reference fasta file were built with Bowtie2
(Langmead and Salzberg, 2012), we then trimmed the adaptor
of the fastQ files with TrimGalore, and mapped reads to the
reference with Tophat2 (Kim et al., 2013). From the aligned reads
from Tophat2, the number of reads per gene were counted with
HTseq and assembled into a matrix containing the read count of
each gene per sample (Anders et al., 2015).
Normalization and transcriptome analysis
Among packages available to test for differential expression,
DESeq2 provides methods suited for the use of replicates; it
uses negative binomial generalized linear models and estimates
dispersion and logarithmic fold changes. We used DESeq2 to
normalize the dataset, generated log2-fold changes and adjacent
P-values (padj) and therefore, to find differentially expressed
(DE) genes in microglia (Love et al., 2014). We first compared
NC to NL to understand gene expression in naïve microglial cells
after in vitro exposure to LPS. Then, due to the lack of replicates,
we were not able to compare second hit microglial cells to their
respective second hit control. Instead, we compared the genetic
expression difference in response to a pre-exposure in vitro to
LPS in NC vs. SHC. Finally, we assessed genetic expression in SHL
compared to NL. A gene was considered differentially expressed
(DE) if its adjacent p-value was strictly lower than 0.1. Pools of
DE up and down regulated genes were clustered and visualized
in heat maps, generated in R using the log2 normalized counts
and the heatmap 0.2 method of the gplots library (Warnes et al.,
2009).
Gene selection and Gene Ontology (GO)
The sheep genome is not yet supported by most gene ontology
platforms, therefore, downstream analyses were performed with
orthologs in the human genome Homo sapiens. ToppGenes and
ToppCluster (Chen et al., 2009; Kaimal et al., 2010) were used
to test for functional annotation enrichment analyses of biologic
process and pathway with a false discovery rate correction of 0.05
(Franceschini et al., 2013). Gene Ontology was then performed
with Gorilla and significant networks (P < 0.03) were selected
for further discussion (Bauer et al., 2008; Eden et al., 2009).
Quantitative Real-Time PCR Analysis
The expression profiles of candidate genes were validated by real-
time qRT-PCR. Total RNAs were subjected to cDNA synthesis
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using a QuantiTech Rev. Transcription Kit (Qiagen). HMOX1
and FBPmRNA were quantified by qRT-PCR using a QuantiFast
SYBR Green PCR Kit (Qiagen) with STRATAGENE 3000 P,
mRNA relative expression was calculated by the 2−11Ct method
over housekeeping gene GAPDH compared to baseline (Livak
and Schmittgen, 2001). Sheep specific HMOX1 primers were
designed with primer3 (Untergasser et al., 2012) and FBP primers
were designed using Integrated DNA Technologies online tool
and listed in Table 1.
Statistical Analyses
Generalized estimating equations (GEE) modeling was used
to assess the effects of LPS while accounting for repeated
measurements on fetal blood gasses and acid-base status,
plasma and in vitro cytokines, cardiovascular responses [AR(1)
correlation matrix to account for temporal structure] and in vivo
Iba1+ fluorescence (independent correlation matrix to deal with
the spatial distribution of Iba1+ fluorescence across the brain
regions). We used a linear scale response model with LPS
and time or brain regions as predicting factors to assess their
interactions using maximum likelihood estimate and Type III
analysis with Wald Chi-square statistics. Correlation analysis
was performed using Spearman correlation coefficient. SPSS
Version 21 was used for these analyses (IBM SPSS Statistics,
IBM Corporation, Armonk, NY). Significance was assumed for
p < 0.05. Results are provided as means ± SEM. Not all
measurements were obtained for each animal studied.
Results
In vivo Studies
Cohorts’ Characteristics
Maternal venous blood gasses, pH, and lactate did not
significantly change during the experiments and were within
physiological range throughout the experiment for both groups.
Maternal and fetal cohort’s characteristics are summarized in
Table 2. Gestational age at time of the experimental day 1
averaged 130 days ± 1.3 dGA (term 145 dGA). Overall, mother
and fetus were considered healthy based upon a physical
examination and laboratory data collected.
Clinical-chemical Data
Clinical-chemical data, reported elsewhere, (Durosier et al., 2015)
are summarized in Table 2 and were within physiological range
for both groups. We found significant time∗LPS interactions for
pH (P = 0.03), pO2, pCO2, lactate, and BE (all P < 0.001).
TABLE 1 | Primers of quantitative real time PCR analysis of HMOX1 and
FBP.
Gene Forward Reverse
name
HMOX1 CACCAAGTTCAAGCAGCTGT CAACCCTGCGAGAAATGTCC
FBP CGAATGTGACGGGAGATCAA GGCATGTTTGTCTTCTTCTGAC
GADPH TGAGATCAAGAAGGTGGTGAAG GCATCGAAGGTAGAAGAGTGAG
Cardiovascular Analysis
As reported (Durosier et al., 2015), we found time-LPS
interactions for mean arterial blood pressure and fetal heart rate
responses (P = 0.015 and P < 0.001, respectively).
Plasma Cytokines Response to LPS
In vivo LPS exposure resulted in a peak of IL-6 at 3 h compared to
baseline. We detected time-LPS interaction for fetal plasma IL-6
(P < 0.001, Figure 1B).
In vivo LPS Effect on Neuroinflammation
To assess the effect of in vivo LPS exposure on
neuroinflammation in situ we measured microglial activation
as Iba1+ immunofluorescence signal. We found a significant
brain region main effect (p < 0.001), but no group main effect
(p = 0.62) and no significant brain region∗group interaction
(p = 0.13) (Figure 1C). Thus, in vivo LPS exposure did not cause
any measurable neuroinflammation as can be seen with higher
doses of LPS using the same microglia marker (Keogh et al.,
2012; Kuypers et al., 2013).
Overall, fetuses responded to the in vivo LPS exposure with
signs of moderate sepsis as evident by the changes observed with
arterial blood gas, pH, lactate, but with no signs of cardiovascular
decompensation. Despite the systemic response to the LPS
challenge, we observed no signs of neuroinflammation in vivo.
In vitro Studies
Having established a moderate LPS-induced in vivo fetal systemic
inflammation paradigm without overt neuroinflammation in
situ, we next aimed to test the functional properties of
microglia exposed to LPS in vivo in an in vitro setting
allowing characterization of microglial cytokine secretion and
transcriptome profiles in response to LPS.
Primary Fetal Sheep Microglia Culture
In vitro studies were conducted in primary cultures derived from
six controls (naïve) and from two in vivo LPS-exposed animals
(SH). We were able to perform 1–2 in vitro replicates per each
animal depending on cell numbers obtained.
TABLE 2 | Maternal and fetal in vivo clinical characteristics.
Characteristics Maternal* Fetal**
Averaged body weight (kg) 76± 11 3.8± 0.9
Gender: control group, male 5/9
Gender: LPS group, male 4/12
Parity: control group 7/9
Parity: LPS group 3/12
pO2 (mmHg) 54± 6 20± 1
pCO2 (mmHg) 41± 2 52± 2
pH 7.44± 0.01 7.37± 0.04
Lactate (mmol/L) 0.7± 0.2 1.5± 0.9
BE (mmol/L) 1.1± 0.2 3.3± 2.3
*Values averaged over the course of the experiment, mean ± SEM.
**Baseline characteristics averaged for control and LPS groups.
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We identified oligodendrocytes and neurons in the initial
cell isolation in addition to microglia and astrocytes (data not
shown). To enrich for microglia we subjected the cells to a
second step as detailed in Methods. To verify cell culture purity,
we performed immunofluorescence staining with a microglia
marker confirming that the isolated primary microglia was very
high (Figure 2A), whereas an astrocyte marker, GFAP, was absent
from the cell population. To further verify cell purity, flow
cytometry CD11b-FITC antibody was performed resulting in
96% of cultured cells are CD11b+ (Figure 2B), further indicating
that a highly pure microglia population was obtained.
We used the purified highly enriched microglia cultures to
pursue the second hit paradigm, i.e., how these cells behave
in vitro in dependence on previous in vivo LPS exposure
(Figure 1A). We found that microglia from in vivo LPS exposed
fetal brain differ in morphology, showing more aggregation or
clumping compared to naïve microglia (Figure 2C). This finding
indicates that these microglia might have already been activated
by LPS exposure in vivo.
Next, we investigated cytokine secretion properties of these
cells in the absence or presence of LPS. For IL-1β, we found
that in vitro LPS administration resulted in increased IL-1β in
microglia compared to control cell cultures; this IL-1β response
was potentiated by 4.6-fold in cells derived from animals with
in vivo LPS exposure: 1884 ± 481 pg/ml vs. 406.14 ± 193 pg/ml
(all p < 0.001, Figure 2D). Moreover, even in the absence of
LPS in vitro, at baseline, microglia from the in vivo LPS group
secreted more IL-1β (208.1 ± 16.63 pg/ml vs. 44.97 ± 59.21
pg/ml) with the fold increase being concordant with the level
of gene expression increase (all P < 0.001, Table 3). Other
pro-inflammatory cytokines of interest such as IL-6 and TNF-
α were undetectable in cell-conditioned media (ELISA data not
shown). Our findings suggest that a pro-inflammatory microglial
phenotype acquired during in vivo exposure to LPS is sustained
in vitro (second hit paradigm).
RNAseq Approach
General overview of the whole transcriptome sequencing
To explore the genomic landscape of fetal sheep microglia,
we sequenced the transcriptome of naïve and “second hit”
microglia. As a quality control, we tested the expression levels of
GFAP and TNFα across our three comparisons, and confirmed
that all cells in our platform shared the same gene expression
characteristics of microglia (Table 3). As a control measure
for cell purity, our data confirmed the presence of TGF-β1
in each sample, as previously reported (Butovsky et al., 2014).
To further confirm cell purity and the findings on protein
level (ELISA), our transcriptome analysis showed a 1.654-
fold increase of IL-1β (log2 = 0.726) between naïve and
second hit LPS-exposed microglia (Table 3, respectively NL
and SHL).
Firstly, we compared gene expression between the naïve
controls and naïve LPS-exposed microglial cells. We found 258
differentially expressed genes (padj < 0.1), among which, 205
genes were up regulated and 53 were down regulated. We
selected relevant differentially expressed genes with ToppCluster
(logP > 4.00) based on their role in the immune response
(Figures 3A,B).
Then, to better understand the effect of an in vivo pre-
exposure to LPS on biological processes, we compared gene
expression between the naïve and second hit controls, i.e., NC and
SHC, respectively. We found 6642 differentially expressed genes,
among which, we identified 4112 up regulated and 2530 down
regulated genes. Selection of relevant genes with ToppCluster
(logP > 4.00) showed that up regulated genes in SHC are mainly
composed of GABA genes and genes responsible for calcium,
potassium, and second messengers transport. Differentially
expressed down regulated genes comprised the genes of the NF-
κB signaling pathway and the HMOX1 gene, responsible for iron
metabolism (log2 = −4.462 and padj = 4.22× 10
−19).
Finally, in an effort to discover the differences in response
between NL and SHL, we compared gene expression of the NL
set of three replicates and SHL (n = 1). We identified a total
of six differentially expressed genes: five were up regulated and
one gene, HMOX1, was strongly down regulated (HMOX1down,
log2 = −4.303 and padj = 8.13 × 10
−2). Among the
five differentially up regulated genes identified, Fructose-1,6-
bisphosphatase (FBP) was uniquely differentially expressed in
second hit LPS-exposed microglia (FBPup, log2 = 4.057 and
padj = 9.40 × 10
−2). The expression profile of HMOX1 and
FBP were assessed by quantitative real-time PCR (qRT-PCR).
The results showed that the expressions of HMOX1 and FBP
were consistent with the expressions from the transcriptome
analyses (Figures 4A,B). The roles of these genes are discussed
below.
Discussion
We established for the first time an in vivo–in vitro endotoxin
double-hit mammalian microglia experimental model to mimic
multiple perinatal neuroinflammation episodes. The isolation of
viable and highly purified microglia populations from in vivo
LPS-exposed brain allowed an in vitro characterization of this cell
type. Our most striking discovery was that the fetal inflammatory
microglial phenotype acquired during in vivo exposure to
LPS, even if not histologically apparent, is sustained and
potentiated in vitro upon re-exposure to LPS. The subsequent
RNA sequencing of the microglial genome revealed a unique
HMOX1down and FBP
up phenotype of microglia exposed to the
double-hit, suggesting interplay of inflammatory and metabolic
pathways.
In vivo–In vitro Model of Perinatal Inflammation
Double-hit
Intrauterine exposure to inflammatory stimuli may switch innate
immunity cells such as macrophages and microglia to a reactive
phenotype (“priming”). Confronted with renewed inflammatory
stimuli during labor or postnatally (especially in preterm
neonates in the intensive care unit), such sensitized cells can
sustain a chronic or exaggerated production of proinflammatory
cytokines associated with neurodevelopmental deficits persisting
into adulthood (double-hit hypothesis) (Larouche et al., 2005;
Spencer et al., 2006; Wang et al., 2006).
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TABLE 3 | Gene expression summary in naïve (one time exposure to LPS in vitro) and second hit (exposed once in vivo and second time in vitro) microglia.
Relevance Gene name (Common name) Naïve microglia Second hit control Second hit
Activated mitochondrial biogenesis SLC2A4 6.386 8.911 0.821
PPARGC1A 4.842 5.835 1.466
Adipocytokine signaling pathway CAMKK1 −1.110 0.511 −0.205
CAMKK2 0.660 1.206 0.453
Adiponectin ADIPOQ 2.422 4.588 1.137
Adrenoceptor alpha 1A ADRA1A 2.572 4.687 −0.471
AMPK signaling pathway PRKAA1 0.169 0.218 −0.643
PRKAA2 2.776 4.784 1.774
PRKAB1 −0.189 −1.319 −2.603
PRKAB2 0.861 0.179 0.066
PRKAG1 −0.379 −3.249 −2.168
PRKAG2 −0.405 −1.194 −0.513
PRKAG3 −1.329 0.099 −0.050
B-cell development and survival TNFSF13B (BAFF) 2.562 −0.955 −1.823
Calcium binding protein 39 CAB39 0.279 −1.520 −1.583
CAB39L −0.076 −1.092 −1.106
Esterase enzyme ACHE −0.036 −0.978 −0.698
BCHE −0.475 −3.197 −1.782
Fractalkine/CX3CR1 axis and biological signature of CX3CR1 2.017 3.079 0.880
microglial cells CX3CL1 0.618 −0.443 0.076
ITGAM (CD11b) 0.130 −0.113 −1.083
IL1B 7.578 1.766 0.726
Fructose-1,6-Biphosphate FBP −0.792 1.465 4.057
Gluconeogenesis and glucolysis ALDOA −0.106 −0.485 0.355
ALDOB −1.659 −1.842 −2.033
ALDOC −0.266 −0.717 0.328
PFKP −0.461 −0.228 0.686
GPI −0.940 −2.001 −0.363
Growth, proliferation, fate determination, ELAVL1 −0.252 −0.986 −0.895
development, immunity CCNA1 2.574 6.259 2.854
CCNA2 0.143 0.098 0.686
IRF9 (p48) 0.407 −1.286 −0.641
PIM1 3.108 −0.815 −2.762
EP300 (CBP) 0.784 0.638 −1.094
CREBBP (CBP) 0.881 0.752 −0.835
CISH (CIS) 7.170 2.217 −2.097
HDAC genes: potential epigenetic regulators HDAC1 2.271 0.145 0.676
HDAC10 −0.242 −0.840 0.116
HDAC11 −0.214 0.867 0.812
HDAC2 −0.299 −2.746 −2.423
HDAC3 0.045 −0.692 0.321
HDAC4 1.292 1.502 −0.691
(Continued)
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TABLE 3 | Continued
Relevance Gene name (Common name) Naïve microglia Second hit control Second hit
HDAC5 −0.869 0.333 0.501
HDAC6 −0.688 −0.126 −0.430
HDAC7 −0.109 0.643 −0.486
HDAC8 0.336 −0.889 −2.510
HDAC9 0.732 1.556 −1.816
Increased FFA oxidation CPT1A −0.260 0.631 0.100
CPT1B 0.496 1.140 0.304
CPT1C 0.608 0.315 0.503
Inhibit cell growth and protein synthesis RPS6KB1 −0.078 −1.659 −1.444
RPS6KB2 −0.569 −1.900 −0.634
EIF4EBP1 −0.822 −2.609 −1.533
PPARG2 −2.093 −2.107 −0.656
Inhibit protein synthesis EEF2 −0.005 0.210 0.421
EEF2K −0.394 0.208 −0.321
Initiators of the JAK-Stat pathway JAK1 0.213 −1.404 −2.112
JAK2 2.289 0.000 −1.430
JAK3 2.965 2.121 −0.920
TYK2 0.948 −0.296 −0.929
STAT1 −0.136 −0.825 −0.563
STAT2 1.276 −1.321 −2.852
STAT3 0.660 −2.050 −0.889
STAT5A 3.365 −0.188 −2.798
STAT5B 1.554 −0.436 −1.093
Insulin signaling pathway IGF1 1.601 2.264 1.177
IGF1R −0.125 −0.489 −0.838
IRS1 1.241 2.665 0.344
IRS4 4.420 7.086 1.953
Iron metabolism and/or anti-inflammatory HMOX1 −2.686 −4.462 −4.303
NRF-2 0.855 −1.235 −1.225
JNK/P38 MAPK MAPK8 (JNK) 0.544 −2.918 −1.173
MAPK9 (JNK) −0.266 −2.257 −2.853
MAPK10 (JNK) 1.492 3.024 −0.262
MAPK12 (P38) −0.905 −0.708 0.458
MAPK13 (P38) 3.294 3.173 0.171
MAPK14 (P38) −0.848 −0.612 0.113
Leptin LEP 5.033 7.429 −0.143
LRP phagocytosis signaling LRP1B 4.522 6.380 0.336
LRP2 4.860 6.571 1.410
LRP6 1.052 1.850 0.157
Lymphocyte adhesion, T-cell costimulation ICAM-1 4.055 −0.181 −2.801
Lymphoid-tissue homing CCL21 18.917 20.916 0.368
CCL19 5.439 5.328 −0.321
mTOR signaling pathway RHEB −0.257 −3.516 −2.292
(Continued)
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TABLE 3 | Continued
Relevance Gene name (Common name) Naïve microglia Second hit control Second hit
AKT1S1 0.908 −0.657 −1.496
MTOR −0.107 −0.234 −1.066
RPTOR 0.298 0.361 −0.625
Myeloiesis and B-cell lymphopoiesis CXCL12 (SDF-1alpha) −0.545 1.552 0.268
NF-kB signaling and inflammation RELB 1.503 −1.389 −1.227
NFKB 2.676 −0.323 −0.200
NFKBIA 2.578 −1.934 −1.546
NFKB1 (p50) 2.569 −0.801 −2.673
RELA (p65) −0.031 −2.098 −2.268
PTGS2 5.166 −0.609 −2.168
TNF 4.990 0.028 −2.743
PTGS2 5.166 −0.609 −2.168
IL8 4.779 −2.847 −3.988
IL1B 7.578 1.766 0.726
TNFAIP3 2.628 −0.542 −3.162
Nitric oxide (NO) and NO production NOS1 6.201 8.416 1.233
NOS1AP 0.386 −0.599 −1.393
NOS2 5.951 3.039 −1.958
NOS3 5.266 7.637 1.112
P53 TP53 −0.554 −0.379 −1.539
MDM4 3.489 −13.081 −1.120
PIK3-Akt signaling pathway PIK3CA 0.018 −1.584 −1.561
PIK3CB 1.793 −0.972 −1.750
PIK3CG 1.950 1.106 −0.094
PIK3R1 1.330 −1.533 −1.884
PIK3R3 1.083 2.066 −1.507
PIK3R5 4.343 2.695 −0.635
PDPK1 0.915 0.946 −0.606
AKT2 −0.335 −0.857 −1.328
AKT3 0.350 0.104 −1.292
TSC1 1.099 0.940 −0.386
TSC2 0.219 0.587 1.182
Quality control TGFBR1 0.327 0.158 −0.943
TGFβ −0.419 −1.798 −0.690
GFAP −1.044 −5.512 −3.709
ITGAM (CD11b) 0.130 −0.113 −1.083
CD40 4.656 2.831 1.352
IBA1 (AIF1) 0.060 0.208 0.956
Serine/threonine kinase 11 STK11 −0.178 −1.553 −1.491
STE20-related kinase adaptor alpha STRADA −0.536 −1.252 −1.293
STRADB −0.506 −2.816 −3.582
Tak1 protein MAP3K7 −0.057 −0.809 −2.136
Toll-like receptor 4 TLR4 0.807 −2.451 −3.749
LY96 (MD-2) 1.213 0.263 0.340
LBP 4.472 5.990 0.172
(Continued)
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TABLE 3 | Continued
Relevance Gene name (Common name) Naïve microglia Second hit control Second hit
Transcription factors C-JUN 0.795 −1.539 −2.385
C-FOS (FOS) −3.072 −1.635 −0.317
NFKB 2.676 −0.323 −0.200
CREB1 0.782 −0.228 0.190
ATF4 (creb TF) 0.968 −0.319 0.163
CEBPB (CEBP) 0.586 −0.993 −1.451
Bold values correspond to a significant log2 fold change (padj < 0.1).
Differential analysis of the count data was done with the DESeq2 package; up regulated genes are highlighted in red and down regulated genes are highlighted in blue. Values in the
column “naïve cells” correspond to fold change from the naïve controls (NC ) to LPS-exposed microglia (NL). In the same way, we compared second hit control (SHC ) to the NC. Fold
changes are summarized in the column “second hit control.” Values in the “second hit” column represent the fold change from NL to second-hit, i.e., LPS re-exposed, (SHL) microglia.
Experimentally induced inflammation in chronically
instrumented non-anesthetized fetal sheep is a well-established
in vivo model of fetal physiology (Prout et al., 2010, 2012).
Primary microglia cultures in different species have been
reported for decades (Stansley et al., 2012). We integrated
both in vivo and in vitro models into a new, hybrid system
adding the layer of the whole transcriptome analysis using
RNAseq analyses. The chief advantage of the new in vivo–in vitro
model presented here is that it allows us to examine microglia
responses to LPS-induced double-hit inflammation in situ and
in vitro on integrative physiological, protein and genomic levels,
and in a physiologically and clinically meaningful context.
This approach has the potential to uncover hitherto unseen
relationships between brain and immune system on different
scales of organization in the perinatal stage of development,
which might accelerate discovery of new treatment strategies.
In vivo, our experimental cohort’s morphometric, arterial
blood gasses, acid-base status and cardiovascular characteristics
were within physiological range and representative for late-
gestation fetal sheep as a model of human fetal development near
term (Frasch et al., 2007; Rurak and Bessette, 2013). As reported
elsewhere (Durosier et al., 2015), the effect of the low LPS dose
we administered on the arterial blood gasses, acid-base status and
cardiovascular responses is compatible with a mild septicemia
(mild compensated metabolic acidemia and hypoxia) evidenced
by a transient rise of IL-6 at 3 h without overt shock, i.e., without
cardiovascular decompensation. Similar levels of systemic IL-6
have been reported (Prout et al., 2010).
In vitro, we developed a new microglia isolation protocol
that combines the human adult and fetal brain microglia
isolation protocols (Durafourt et al., 2013) and successfully
collected a highly enriched microglia population. The use of a
modified cell isolation approach from fetal brain tissue is mainly
due to the higher degree of myelination in the adult human
brain compared to that of a near-term fetus (Durafourt et al.,
2013). We were able to attain high purity of microglia, which
we validated by flow cytometry and immunocytochemistry.
Moreover, RNAseq showed a consistent and constant low level of
expression of the astrocyte marker GFAP further confirming cell
purity.
In this study, the morphology of microglia from in vivo LPS
exposed fetal brain was distinguished by more aggregation or
clumping and less ramification compared to naïve microglia
(Suzuki et al., 2006; Henkel et al., 2009). This suggests that
microglia exposed to LPS in vivomay have been already activated
before plating in cultures.
Single-hit LPS Exposure In vitro Results in Up
Regulation of Inflammatory Pathways JAK-STAT
and NFKB and Down Regulation of Metabolic
Pathways
Gene ontology analyses of DE genes in NL microglia revealed
an up regulation of inflammatory pathways NFκB, PIK3-Akt,
and Jak-STAT. Interestingly, this was accompanied by a down
regulation of metabolic pathways in LPS-induced inflammatory
response (Figures 3A,B and Table 3). These findings may be
explained, at least in part, by the emerging role of energy-sensing
AMPK signaling in microglia, which links the inflammatory and
metabolic regulatory networks (Frasch, 2014), We will return
to this observation in Section Double-hit LPS Exposure of
Microglia In vivo and In vitro Is Uniquely Characterized By a
HMOX1down/FBP
up Phenotype.
Among differentially expressed genes selected, NFKB (log2 =
2.676 and padj = 4.58 × 10
−2) and JAK3 (log2 = 2.965
padj = 2.49 × 10
−3) were up regulated in NL microglia.
We then investigated the expression of genes involved in the
NFκB and JAK-Stat pathways; our data showed that IL1B
(log2 = 7.578), TNF (log2 = 4.990), NFKBIA (log2 = 2.578
and padj = 9.09 × 10
−2), and RELB (log2 = 1.503) were up
regulated in NL microglia. Gene ontology analysis revealed down
regulation of the energy consuming processes and up regulation
of energy conserving processes, as evidenced by the down
regulation of genes related to glycolysis (GPI) and up regulation
of gluconeogenesis (FBP) and the insulin signaling pathway.
Furthermore, Gene Ontology of up regulated genes revealed that
the GO term “immune system process” clustered key genes of
inflammatory pathways, such as, JAK3, NFKBIA, and NFKBIB
(GO:0002376 and P = 9.56 × 10−8). Differentially expressed
down regulated genes also affected “the immune system process”
(GO:0002376 and P = 3.24 × 10−4) and cellular response to
metal ion (GO: 0071248 and P = 6.05 × 10−6). HMOX1 and
FOS clustered in both GO terms underlying the potential role of
HMOX1 in the immune system in relation with FOS. Analysis
of all down regulated genes showed that the “metabolic process”
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FIGURE 3 | Heat maps of the gene expression in microglia cells
exposed to LPS. Selected up regulated (red) and down regulated (blue)
genes are listed; genes were selected with ToppCluster based on their
significance in the immune response (logP > 4.00) (A) Heat map of 205
differentially expressed (padj < 0.1) up regulated genes (red) in NL microglia.
(B) Heat map of 53 differentially expressed down regulated genes in NL
microglia, among selected genes indicated in blue, HMOX1 was strongly
differentially expressed (log2 = −2.686 and padj = 3.09× 10
−8). In both up
and down regulated genes, we observed a different behavior for NL3 that did
not affect our differential analysis. (C) Heat map of the 4112 most
differentially expressed and up regulated genes in SHC compared to NC
cells. Selected genes with ToppCluster (logP > 4.00) include GABA receptor
genes and genes related to the transport of ion, Calcium, Sodium, and
Potassium. IL1B was up regulated with log2 = 1.766 (padj = 1.53× 10
−3)
corresponding to a 3.40-fold increase (D) Among the 2530 most differentially
expressed and down regulated genes identified, HMOX1 was significantly
down regulated (log2 = −4.462 and padj = 4.22× 10
−19). The reported
genes were selected with ToppCluster (logP > 4.00) for their implication in
the inflammatory response. (E) Differentially expressed up and down
regulated genes in SHL compared to NL microglia. HMOX1 was the only
down regulated gene (log2 = −4.303, padj = 8.13× 10
−2). When comparing
common genes in SHC and SHL cells, the gene FBP was unique to SHL (red
rectangle). NC, Naïve control microglia; NL, Naïve LPS-exposed microglia;
SHC, Second hit control microglia; SHL, Second hit LPS-exposed microglia.
(GO:0008152 and P = 2.38 × 10−8) was also globally affected
(data not shown).
Double-hit LPS Exposure of Microglia In vivo and
In vitro is Uniquely Characterized By a
HMOX1down/FBP
up Phenotype
Interestingly, HMOX1 gene expression showed a strong down
regulation in SHL and SHC by four-fold (Table 3, Figures 3D,E).
The level of expression of HMOX1 was higher in SHC than in
SHL (log2 = −4.462 and padj = 4.22 × 10
−19; log2 = −4.303
and padj = 8.13 × 10
−2, respectively). Such differences in
response patterns were observed in other genes as well suggesting
a memory of inflammation induced by pre-exposure to LPS in
vivo.
HMOX1 role in microglia is yet to be fully understood.
Across the three group comparisons (Figure 1A), HMOX1 was
significantly down regulated and in vivo pre-exposure to LPS
seemed to further enhance the down regulation of HMOX1 in
response to second-hit in vitro LPS stimulation. We confirmed
by RT-PCR that transcript amounts of HMOX1 are low in NL
and SHL microglia (Figures 4A,B). HMOX1 was suggested to
play an anti-inflammatory role in LPS-induced murine adult cell
line macrophages via the activation of the Nrf2/ARE pathway
(Ye et al., 2014). Pre-treatment with Oroxylin A, an inhibitor of
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FIGURE 4 | Validation of RNAseq findings by qRT-PCR analysis of
HMOX1 and FBP. (A) Quantification of HMOX1 in each NL microglia
compared to averaged-NC. (B) Quantification of HMOX1 and FBP in SHL
compared to averaged-NL microglia. Avg, Averaged; NC, Naïve control
microglia; NL, Naïve LPS-exposed microglia; SHL, Second hit LPS-exposed
microglia.
LPS-induced mRNA, substantially increased the levels of NRF-2
and heme oxygenase 1. The response of SHC and SHL compared
to their single-hit microglia counterpart NL showed thatHMOX1
and NRF-2 had a greater down regulation after pre-exposure to
LPS in vivo (Table 3), supporting the potential role of HMOX1
in the inflammatory response and as a determinant of microglial
phenotype.
While the role of FBP in inflammation is unclear, its
neuroprotective effect in brain injury models was suggested
through various mechanisms. During hypoxia, FBP supports
ATP production via stimulation of glycolysis which results
in maintenance of normal intracellular calcium levels via the
phospholipase-C dependent MAP kinase signaling pathway
(Bickler and Kelleher, 1992; Fahlman et al., 2002). When
comparing gene expression in SHC (Figures 3C,D), we observed
that genes responsible for the transport of calcium, potassium
and second messengers were also differentially expressed and up
regulated.
It was previously reported that FBP dose-dependently
suppressed LPS-induced nitric oxide (NO) production, and
higher FBP doses were also associated with decreased levels of the
transcription factor activator protein AP-1 in primary neonatal
murine microglia cultures (Kim et al., 2012). We confirmed
this observation in our comparison of SHL to SHC, wherein
we observed that up regulation of FBP was concordant with
lower expression of NOS1AP (log2 = −1.393) suggesting lower
production of NO. We also observed that lower FBP transcripts
amount in NL was accompanied by higher expression level of
NOS production related genes (Table 3). The authors observed
that FBP had an effect on the binding of transcription factors to
DNA: FBP diminished the binding of AP-1 to DNA, but NFKB
and CREB did not seem affected. We found down regulation of
AP-1 (log2 = −2.385) and a slight down regulation of NFKB
and CEBP, though CREB1 remained unaffected. In the SHL, our
results confirmed that DNA binding nuclear factors were not
strongly down regulated upon higher transcript level of FBP.
The authors suggested that FBP inhibits iNOS expression by
blocking the JNK/p38 MAPK pathway. We confirmed that JNK
related genes may have lower expression level, however we did
not observe any marked difference for P38.
A common theme within the newly found
HMOX1down/FBP
up phenotype appears to be its memory
of the “energy restoring direction” following in vivo exposure
to LPS. This metabolic effect is evidenced for example by
up regulation of AMPK, insulin, growth arrest processes,
mitochondrial biogenesis signaling pathways and down
regulation of mTOR signaling pathway and such energy
consuming processes as cell growth and protein synthesis (cf.
Table 3).
Does In vivo Endotoxin Exposure Induce
Transcriptome Memory of Inflammation in Fetal
Microglia Mediated By Epigenetic Mechanisms?
Pre-exposure to LPS in vivo affected globally the transcriptome
of microglia (Table 3). We observed that SHC microglia had
a diminished response in gene expression of inflammatory
pathways NF-κB, JAK-Stat, and PIK3-Akt compared to the
behavior of the NL microglia; this phenomenon was sustained
in SHL microglia. As mentioned in Section Double-hit LPS
Exposure of Microglia in vivo and In vitro Is Uniquely
Characterized By a HMOX1down/FBP
up Phenotype, this was also
true for the metabolic pathways. This desensitization was also
observed in histone deacetylase 1 (HDAC1 and 6), which was
DE up regulated by two-fold in NL (log2 = 2.271 and padj =
8.58× 10−2), and up regulated by less than one-fold in SHC and
SHL (log2 = 0.676 and log2 = 0.145, respectively, Table 3).
This HDAC1 profile was accompanied by a less than one-fold
down regulation of HDAC6 (log2 = −0.688 and padj = 8.75 ×
10−2) followed again by desensitization in microglia exposed to
LPS in vivo. HDAC4 was 2.5-fold up regulated (log2 = 1.292
and padj = 0.133) in NL vs. NC microglia followed also by
desensitization in the comparison to the in vivo pre-exposed
microglia; meanwhile,HDAC2 showed a less than one-fold down
regulation (log2 = −2.746 and padj = 2.30 × 10
−4) in NC vs.
SHC microglia, with no detectable change in microglia exposed
to LPS in vitro only or upon double-hit exposure. In parallel,
HMOX1 was down regulated by four-fold in SHL and SHC,
and by two-fold in NL microglia, and did not seem to have
a diminished response in SHL. These findings underscore the
potential role of HDAC1, 2, 4, and 6 in the memory of the
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in vivo exposure to inflammation in line with the histone code
hypothesis (Jenuwein and Allis, 2001).
In light of the putative epigenetic mechanisms underlying our
findings of single- and double-hit LPS signatures in microglial
transcriptomes, it remains to be tested whether these signatures
are indeed unique to LPS or apply more widely for perinatal
exposures to other stressors, such as the psychosocial stress, e.g.,
caused by fear (Shapiro et al., 2013; Monteleone et al., 2014;
Metz et al., 2015). Forced-swim stress applied over 4 days in
adult male mice induced changes lasting at least two following
weeks in neuronal acetylcholine esterase (AChE) expression via
an epigenetic mechanism of hypoacetylation, with near-exclusive
enrichment of HDAC4, and hypermethylation of histone H3K9
at a specific promoter of AChE (mP1c) with resulting suppression
of the mE1c exon expression levels (Meshorer et al., 2002; Sailaja
et al., 2012). Interestingly, a non-exclusive increase of HDAC-1,
2, and 7 was also detected. Animals showed anxiety-like behavior
and this behavior as well as the AChE chromatine structure and
the entire HDAC enrichment profile were reversed by NaBu,
an HDAC inhibitor; the restoration of mE1c expression level
was however due to HDAC4 inhibition entirely. AChE-R is the
alternative splicing soluble variant of AChE-S in neurons; AChE-
R production increases under various stress influences (Soreq
and Seidman, 2001). This splicing switch can be induced by
short-lasting (minutes) stress exposures, but can then last for
weeks as shown in adult neuronal and hippocampal slice cultures
(Meshorer et al., 2002; Sailaja et al., 2012). NaBu restored this
splicing switch with regard to reduction in AChE-R, although the
renewed increase of AChE-S variant was incomplete compared to
the non-stressed animals. This finding is particularly interesting,
as it sheds a new light on how stress may modulate inflammation
via epigenetic mechanisms impacting the pro-inflammatory
AChE. AChE inhibition restricts inflammation not only in the
peripheral organs, but also in the brain (Pollak et al., 2005). The
incomplete restoration of AChE-S suggests a complex regulatory
network controlling AChE-S/AChE-R ratio in response to
stress. Ultimately, such shifts in AChE presence in intercellular
space may have long-lasting effects on cholinergic transmission
with regard to cognition (cf. Section Microglial LRP-mediated
Neuronal Phagocytosis May Be Enhanced By In utero Exposure
to Inflammation) and neuroinflammation. Adding to the
complexity of epigenetic regulation of cholinergic signaling and
neuroinflammation, microRNA (miRNA)-132 has been shown
in adult murine model and cell lines to potentiate cholinergic
anti-inflammatory signaling in the periphery, myeloid cells in
particular, and in the brain by inhibiting AChE expression
(Shaked et al., 2009). The role of miRNA-132 in microglia is
not yet known, but the evidence is growing for the overall
importance of miRNA signaling in determining the polarization
and phenotype of microglia and myeloid cells in general
(Ponomarev et al., 2013).
Fear represents a model system to study chronic impact
of stress on epigenome and cardiovascular system (Shenhar-
Tsarfaty et al., 2015). As noted above, this approach may
relate conceptually to our current findings bringing together
the effects of in vivo endotoxin exposure as a stressor on the
brain’s microglial transcriptome and the cardiovascular system.
Interestingly, changes in miRNA-608 activity on AChE binding
sites in the brain (e.g., due to single nucleotide polymorphisms,
SNPs) concomittantly raise levels of anxiety and blood pressure
in adult mice and humans by decreasing the inhibition of
AChE expression, while reducing CDC42 and IL-6 levels,
important pro-inflammatory mediators (Hanin et al., 2014).
This link between epigenetic signaling mechanisms, stress, and
cardiovascular system is further strengthened by the recent study,
in adult humans showing synergistic effects of fear as a stressor on
heart rate and inflammation with cholinergic signaling playing a
central role in modulating both systems (Shenhar-Tsarfaty et al.,
2014, 2015). We found an increase of heart rate and a slight
drop of blood pressure within the time frame of the IL-6 peak
following LPS injection to the ovine fetus (Durosier et al., 2015).
However, this effect appeared to dissipate at 54 h following the
initial LPS exposure. Still, our experimental design does not allow
drawing conclusions whether such intrauterine exposure to low-
dose endotoxin concentrationsmay induce lasting cardiovascular
changes along with alterations in innate immune responses upon
repeated exposure to inflammatory stimuli. This remains subject
of future studies. Interestingly, BCHE, but not ACHE, showed
DE and less than one-fold down regulation (log2 = −3.197
and padj = 6.86 × 10
−3) in NC vs. SHC microglia, with no
detectable change in microglia exposed to LPS in vitro only or
upon double-hit exposure; both BCHE and ACHE were also less
than one-fold down regulated, but not differentially expressed in
all other comparisons. In this regard, the potential role of serum
cholinesterases as easily accessible biomarkers of neuroimmune
function, along with heart rate variability monitoring, present
an attractive opportunity to translate these insights into bedside
applications to improve perinatal health outcomes (Durosier
et al., 2015; Lake et al., 2014; Shenhar-Tsarfaty et al., 2014).
In summary, microglia pre-exposed to inflammation in vivo
seem to acquire a memory of inflammation that reflects on the
transcriptome by an overall decreased response in inflammatory
pathways while the production of the pro-inflammatory cytokine
IL-1β is up regulated. In light of the above discussion, our
findings lend support to the notion of an inflammation memory
in SHC sustained in SHL microglia that may be mediated by
epigenetic regulatory processes involving histone acetylation and
miRNA signaling. The intriguing link to the metabolic processes
and cardiovascular system also deserves attention in future
studies. Additional mechanistic studies (knockout, knockdown,
or overexpression) are needed to validate these observations.
Microglial LRP-Mediated Neuronal Phagocytosis
May be Enhanced By In utero Exposure to
Inflammation
Calreticulin (CRT) exposure on the surface of viable or apoptotic
neurons is required for their phagocytosis via low-density
lipoprotein receptor-related protein (LRP) receptors on LPS-
stimulated primary culture rat microglia (Fricker et al., 2012).
We found that the gene LRP6 is significantly up regulated after
LPS exposure in vitro in NL microglia (log2 = 1.052 and padj =
2.76 × 10−2) and the activation of LRP6 is sustained in vitro
in SHC microglia (log2 = 1.850 and padj = 5.58 × 10
−3), i.e.,
after the LPS exposure in vivo. LRP1B (log2 = 6.380 and padj =
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5.66 × 10−5) and LRP2 (log2 = 6.571 and padj = 4.24 × 10
−11)
were also strongly up regulated in SHC microglia. LRP1B and
LRP2 showed a four-fold up regulation in NL microglia, however,
adjacent p-values were not consistent to support this observation.
We show that a single LPS exposure in vivo or in vitro suffices
to up regulate LRP genes suggesting that in utero exposure to
inflammation may alter microglial—neuronal communication
making CRT expressing neurons vulnerable to LRP-mediated
phagocytosis. Our data does not allow validating the idea that
double hit exposure to an inflammatory stimulus enhances
up regulation of microglial LRP, because we could not test
directly SHL vs. SHC (cf. SectionMethodological Considerations,
Discussion on limitations of RNAseq approach). Future studies,
should estimate genetic expression profile of SHL compared
to SHC.
Methodological Considerations
We could not detect any in situ neuroinflammation using Iba1, a
well-established myeloid cell marker in sheep and other species.
Despite the lack of overt neuroinflammation seen in situ we
demonstrated a pattern of LPS-induced systemic IL-6 cytokine
production in vivo and microglial IL-1β cytokine secretion
in vitro. This further supports the notion that even subtle LPS
exposures in utero in vivo may polarize microglia toward a
neuroinflammatory phenotype without or with secondary re-
exposure to an inflammatory stimulus. The LPS-triggered rise of
IL-6 in plasma is in line with animal and human studies at this
developmental stage (Duncombe et al., 2010; Chan et al., 2013).
Microglia in vitro have been shown to secrete IL-1β preferentially
when challenged with LPS, while IL-6 secretion is a hallmark of
cultured astrocytes in rat (Gottschall et al., 1994). Our findings
are consistent with literature and further support the cell culture
purity.
In parallel to our team, the feasibility of creating a mixed
primary fetal ovine brain culture has been recently, demonstrated
(Weaver-Mikaere et al., 2012). We have advanced this work by
focusing on late rather than mid-gestation fetuses and creating
primary pure microglial culture rather than mixed culture. This
allowed us to then study the microglia-specific effects of the
double hit in vivo/in vitro LPS exposure on the secretion profile
of the inflammatory cytokine IL-1β and the high-throughput
transcriptome.
In this study, we did not discriminate between the various
phenotypes of the endogenous microglia as well as the microglia
recruited to the brain during the inflammatory process via
the blood brain barrier, whose permeability increases under
conditions of hypoxia/ischemia and fetal inflammatory response
(Hutton et al., 2007, 2008; Butovsky et al., 2014; Yamasaki et al.,
2014; Greter et al., 2015; Sadowska et al., 2015). Considering the
mild, low-dose LPS exposure, we speculate that no recruitment
of peripheral monocytes was triggered. However, we cannot state
with certainty whether the microglial memory of inflammation
was entirely newly established upon in vivo LPS exposure,
or certain pre-existing sub-populations of microglia responded
differentially to the endotoxin; another possibility needing
validation remains that progenitor cells from the periphery
differentiated accordingly. Hence, future studies, perhaps using
single cell RNAseq, will elucidate whether the “memory”
is entirely newly established, carried by a subpopulation of
endogenous or periphery-recruited microglia. Isolating single
cells and expanding them in culture may be another approach
to test these hypotheses.
In our approach, we used DESeq2 to normalize read
counts and identify differentially expressed genes. DESeq2 was
specifically designed to estimate differential expression in a
dataset containing replicates for both control and treatment
samples. Our method used a large number of animals allowing us
to have replicates for naïve control and LPS-exposed microglia.
However, a limitation of our RNAseq analysis is the lack of
replicates for SHC and SHL preventing us from comparing
SHC to SHL directly. Other platforms meant to analyze samples
without replicate could have been used here. However, we chose
not to disrupt the analytical pipeline and keep the statistical
analysis consistent throughout the analysis. Despite quality
control measures prior to sequencing, the sample NL3 had a
different expression pattern than the two other NL samples. We
believe it is not related to RNA quality, and may have been due
to environmental or other physiological conditions of the animal
that we were not aware of at the time of the experiment. In
interrogating the differential gene expression, we have ensured
that the partially deviating pattern observed in sample NL3 did
not confound our findings (Figures 3A,B).
Conclusions
Inflammatory microglial phenotype acquired during in vivo
exposure to LPS is sustained and potentiated in vitro upon re-
exposure to LPS. We identified a uniqueHMOX1down and FBP
up
phenotype of microglia exposed to the double-hit. Our results
also suggest that microglia may have acquired in vivo a memory
of inflammation regulated by an epigenetic process that should
be confirmed by further epigenomic studies. This model allows
studying mechanisms of fetal neuroinflammation in utero in vivo
and in vitro to identify potential therapeutic targets for early
postnatal intervention to prevent brain injury.
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